News

Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
ENA Respiratory begins Phase 2a dosing of nasal antiviral INNA-051
read more
Advanced Therapies,Biotech & Pharma Business,Research & Development
Circio raises NOK 200M (€18.6M) to advance in vivo CAR-T programme
read more
Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
AstraZeneca advances oral COPD drug into Phase 2b trial
read more
Biotech & Pharma Business,Manufacturing & Supply Chain,Medical devices,Research & Development
Fuse Diagnostics raises £1M to scale rapid molecular testing platform
read more
Central Nervous System,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Amyl Therapeutics raises €8.25M to advance pan-amyloid neurodegenerative disease platform
read more
Clinical & Regulatory,Digital & Data,Research & Development
CluePoints brings AI-powered clinical data review to DPHARM 2026
read more
Digital & Data,Drug Discovery & Development,Research & Development
NVision deploys quantum-enhanced MRI platform at Hokkaido University
read more
Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
L-glutamine shows 44% response rate in Phase 1 pancreatic cancer trial
read more
Digital & Data,Manufacturing & Supply Chain
Systech launches AI-assisted pharmaceutical traceability platform
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Therapeutic Areas
Karyopharm seeks FDA accelerated approval for selinexor in myelofibrosis
read more
Drug Delivery & Formulation,Manufacturing & Supply Chain,Research & Development
Evonik invests €93M in new GMP LNP manufacturing facility
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Kazia reports 83% response rate for paxalisib in triple-negative breast cancer
read more
Central Nervous System,Drug Discovery & Development,Research & Development,Therapeutic Areas
$3M funding targets tau-driven neurodegenerative diseases
read more
Drug Delivery & Formulation,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Cancer vaccine research secures $2.5M NIH award for nanoparticle treatment
read more
Clinical & Regulatory,Pharmaceuticals and therapeutics
FDA approves Protagonist’s Mimrylo for polycythemia vera, triggering $275M in payments
read more
Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas
Isomab data support safety of angiogenic approaches in coronary artery disease
read more

ENA Respiratory begins Phase 2a dosing of nasal antiviral INNA-051

Circio raises NOK 200M (€18.6M) to advance in vivo CAR-T programme

AstraZeneca advances oral COPD drug into Phase 2b trial

Fuse Diagnostics raises £1M to scale rapid molecular testing platform

Amyl Therapeutics raises €8.25M to advance pan-amyloid neurodegenerative disease platform

CluePoints brings AI-powered clinical data review to DPHARM 2026

NVision deploys quantum-enhanced MRI platform at Hokkaido University

L-glutamine shows 44% response rate in Phase 1 pancreatic cancer trial

Systech launches AI-assisted pharmaceutical traceability platform

Karyopharm seeks FDA accelerated approval for selinexor in myelofibrosis

Evonik invests €93M in new GMP LNP manufacturing facility

Kazia reports 83% response rate for paxalisib in triple-negative breast cancer

$3M funding targets tau-driven neurodegenerative diseases

Cancer vaccine research secures $2.5M NIH award for nanoparticle treatment

FDA approves Protagonist’s Mimrylo for polycythemia vera, triggering $275M in payments

Isomab data support safety of angiogenic approaches in coronary artery disease

main menu

recent posts

Big Picture Bio launches with £2.2M to design cancer drug combinations

SKY-0515 shows 1.59-point cUHDRS difference in Huntington’s disease study

Oncodesign Services and Nexus BioQuest form preclinical research partnership

get connected